FINWIRES · TerminalLIVE
FINWIRES

$TAK

10 stories mentioning TAKUpdated 15d ago

Every FINWIRES story that references TAK, newest first.

Asia Markets

Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

Asian equities traded in the US as American depositary receipts were tracking lower Friday morning, declining 0.48% to 2,877.67 on the S&P Asia 50 ADR Index, which is down marginally for the week so far.From North Asia, the gainers were led by education company Four Seasons Education (FEDU) and brand platform 36Kr (KRKR), which climbed 6.8% and 6.7% respectively. They were followed by automotive marketplace Token Cat (TC) and pharmaceutical company Takeda Pharmaceutical (TAK), which advanced 6.1% and 2.6% respectively.The decliners from North Asia were led by video display maker LG Display (LPL) and semiconductor company ASE Technology (ASX), which fell 4.6% and 4% respectively. They were followed by fintech firm High Templar Tech (HTT) and semiconductor company Silicon Motion Technology (SIMO), which were down 3.4% and 2.7% respectively.From South Asia, the gainers were led by IT companies Infosys (INFY) and Wipro (WIT), which increased 2.8% and 2% respectively. They were followed by lender HDFC Bank (HDB) and telecommunications operator PLDT (PHI), which rose 1.4% and 0.3% respectively.The decliners from South Asia were led by computer hardware maker Canaan (CAN) and tech conglomerate Sea (SE), which dropped 2.8% and 1.4% respectively. They were followed by IT firm Sify Technologies (SIFY), which was off 0.4%.

$ASX$CAN$FEDU$HDB$HTT$INFY$KRKR$LPL$PHI$SE$SIFY$SIMO$TAK$TC$WIT
Sectors

Sector Update: Healthcare Stocks Mixed in Afternoon Trading

Healthcare stocks were mixed Friday afternoon, with the NYSE Healthcare Index increasing 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.3%.The iShares Biotechnology ETF (IBB) was up 0.1%.In corporate news, Intuitive Surgical (ISRG) shares fell past 12%. Growth in the company's da Vinci robotic surgery procedures in the US moderated due in part to changes in Affordable Care Act premium subsidies, even as it reported better-than-expected quarterly results.GSK (GSK) shares were down 2.7% after it said Friday it will discontinue development of camlipixant for refractory chronic cough after the drug produced mixed results in the phase 3 CALM-1 and CALM-2 trials.Takeda Pharmaceutical (TAK) shares rose 2%. The company said late Thursday that new phase 3 data showed its oral TYK2 inhibitor, zasocitinib, delivered high rates of skin clearance across difficult-to-treat body sites in adults with moderate-to-severe plaque psoriasis.

$GSK$ISRG$TAK
Asia Markets

Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading

Asian equities traded in the US as American depositary receipts were falling on Friday morning, down 1.8% to 2,865.59 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by tech company Youdao (DAO) and used car retailer Uxin (UXIN), which advanced 4.5% and 3.4% respectively. They were followed by pharmaceutical company Takeda (TAK), which climbed 2.9%.The decliners from North Asia were led by semiconductor company United Microelectronics (UMC) and electric vehicle maker Xpeng (XPEV), which fell 5.5% and 5.1% respectively.They were followed by Mizuho Financial (MFG) and semiconductor company ASE Technology (ASX), which dropped 4.1% and 3% respectively.From South Asia, the gainers were led by telecoms Telkom Indonesia (TLK) and PLDT (PHI), which rose 2.9% and 1.6% respectively.The decliners from South Asia were led by tech conglomerate Sea (SE), which fell 4%, followed by technology company Sify Technologies (SIFY), which was down 2.2%.

$ASX$DAO$MFG$PHI$SE$SIFY$TAK$TLK$UMC$UXIN$XPEV
Sectors

Sector Update: Healthcare Stocks Mixed Premarket Friday

Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.4% and the iShares Biotechnology ETF (IBB) 0.7% lower.GSK (GSK) shares were down more than 3% after the company said it will discontinue development of camlipixant for refractory chronic cough after the drug produced mixed results in the phase 3 CALM-1 and CALM-2 trials.Novartis (NVS) shares were up more than 1% after the company said the US Food and Drug Administration approved Fabhalta under the traditional approval pathway to slow kidney function decline in adults with primary immunoglobulin A nephropathy at risk of disease progression.Takeda Pharmaceutical (TAK) shares were 0.6% higher after the company said new phase 3 data showed its oral TYK2 inhibitor, zasocitinib, delivered high rates of skin clearance across difficult-to-treat body sites in adults with moderate-to-severe plaque psoriasis.

$GSK$IBB$NVS$TAK$XLV
Asia Markets

Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading

Asian equities traded in the US as American depositary receipts were surging higher Thursday morning, climbing 2.22% to 2,904.10 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by lender Shinhan Financial Group (SHG) and utilities company Korea Electric Power (KEP), which rose 8% and 4.7% respectively. They were followed by pharmaceutical company Takeda Pharmaceutical (TAK) and automotive company Honda Motor (HMC), which were up 3.6% and 3.4% respectively.The decliners from North Asia were led by automotive marketplace Token Cat (TC) and real estate management and digital security company Eason Technology (DXF), which plunged 37% and 30% respectively. They were followed by automotive marketplaces Uxin (UXIN) and Autohome (ATHM), which decreased 6.2% and 3.5% respectively.From South Asia, the gainers were led by computer hardware maker Canaan (CAN) and IT firm Infosys (INFY), which advanced 4.2% and 3% respectively. They were followed by tech conglomerate Sea (SE) and telecommunications operator PLDT (PHI), which increased 2.2% and 2% respectively.The decliners from South Asia were led by fintech firm Trident Digital Tech (TDTH) and IT company Sify Technologies (SIFY), which fell 1.2% and 1% respectively. They were followed by IT company Wipro (WIT) and lender HDFC Bank (HDB), which were off 0.2% and 0.1% respectively.

$ATHM$CAN$DXF$HDB$HMC$INFY$KEP$PHI$SE$SHG$SIFY$TAK$TC$TDTH$UXIN$WIT
Sectors

Sector Update: Healthcare Stocks Rise Pre-Bell Thursday

Healthcare stocks were rising pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.3% higher and the iShares Biotechnology ETF (IBB) up 0.4%.Ensign Group (ENSG) shares were up more than 2% after the company said it has purchased the real estate and operations of two skilled nursing facilities in Texas.Hutchmed (HCM) stock was up more than 6% after the company said China's National Medical Products Administration granted conditional approval to marketing application of its therapy, Orpathys, to treat certain patients with locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.Takeda Pharmaceutical (TAK) has partnered with Insilico Medicine to use the latter's Pharma.AI platform to advance drug candidates across selected therapeutic areas, Hong Kong-listed Insilico said. Shares of Takeda Pharmaceutical were up more than 2% premarket.

$ENSG$HCM$IBB$TAK$XLV
Asia Markets

Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

Asian equities traded in the US as American depositary receipts fell Tuesday morning, tumbling 3.1% to 2,816.27 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by mobile app developer Cheetah Mobile (CMCM) and pharmaceutical company Takeda Pharmaceutical (TAK), which rose 2% each. They were followed by travel company Tuniu (TOUR), which was up 0.1%.The decliners from North Asia were led by fintech firm Jiayin Group (JFIN) and semiconductor company ASE Technology (ASX), which fell 29.9% and 7.6% respectively. They were followed by video display maker LG Display (LPL) and semiconductor company Silicon Motion Technology (SIMO), which shed 6.9% and 6.4% respectively.From South Asia, the gainers were led by IT firm Wipro (WIT) and telecommunications operator Telekomunikasi Indonesia (TLK), which increased 3.1% and 1.5% respectively. They were followed by IT firm Infosys (INFY) and pharmaceutical company Dr. Reddy's Laboratories (RDY), which advanced 1% each.The decliners from South Asia were lenders ICICI Bank (IBN) and HDFC Bank (HDB), which were down 1% and 0.5% respectively.

$ASX$CAN$CMCM$IBN$INFY$JFIN$LPL$RDY$SIFY$SIMO$TAK$TDTH$TLK$TOUR$WIT
Asia Markets

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading

Asian equities traded in the US as American depositary receipts opened the trading week sharply higher Monday morning, rising 1.19% to 2,889.22 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by electric vehicle maker NIO (NIO) and semiconductor company Himax Technologies (HIMX), which climbed 6.8% and 6.3% respectively. They were followed by fintech firm Qfin (QFIN) and entertainment streaming service Bilibili (BILI), which advanced 5.8% and 5.1% respectively.The decliners from North Asia were led by real estate management and digital security company Eason Technology (DXF) and mobile app developer Cheetah Mobile (CMCM), which shed 20% and 6.4% respectively. They were followed by solar panel maker JinkoSolar (JKS) and pharmaceutical company Takeda Pharmaceutical (TAK), which dropped 5.4% and 4.2% respectively.From South Asia, the gainers were led by tech conglomerate Sea (SE) and IT firm Infosys (INFY), which rose 5.3% and 2.5% respectively. They were followed by telecommunications operators Telekomunikasi Indonesia (TLK) and PLDT (PHI), which were up 0.4% and 0.1% respectively.The decliners from South Asia were led by computer hardware maker Canaan (CAN) and IT firm Sify Technologies (SIFY), which fell 3.8% and 2.9% respectively. They were followed by pharmaceutical company Dr. Reddy's Laboratories (RDY) and lender ICICI Bank (IBN), which were down 2.1% and 1.3% respectively.

$BILI$CAN$CMCM$DXF$HIMX$IBN$INFY$JKS$NIO$PHI$QFIN$RDY$SE$SIFY$TAK$TLK
Wire

Jury Orders Takeda to Pay Hundreds of Millions in Antitrust Case, Bloomberg Reports

Jury Orders Takeda to Pay Hundreds of Millions in Antitrust Case, Bloomberg Reports

$TAK
Wire

Protagonist Therapeutics Opts Out of Rusfertide US Profit-Sharing Arrangement With Takeda Pharmaceutical

Protagonist Therapeutics (PTGX) exercised its right to opt out of the 50/50 US profit and loss sharing arrangement under its global license and collaboration agreement with Takeda Pharmaceutical (TAK) for rusfertide, Protagonist Therapeutics said Tuesday.As a result, Protagonist Therapeutics will be eligible to receive up to $400 million in opt-out payments.The company will also be entitled to a $75 million milestone payment upon rusfertide's approval in the US and up to $975 million in other milestone payments and tiered royalties on net sales, according to the statement.Takeda Pharmaceutical now holds exclusive development and commercialization rights to rusfertide in the US.Rusfertide is under FDA Priority Review in the US for the treatment of adult patients with polycythemia vera, Protagonist Therapeutics said.Price: $99.31, Change: $+0.84, Percent Change: +0.85%

$PTGX$TAK

Track with the FINWIRES app suite

FolioX
FolioX
Track TAK in your portfolio
WheelAI
WheelAI
Analyze TAK options with the wheel strategy
StockInsider
StockInsider
See market sentiment on TAK